News
Merck has characterized its cost-cutting initiative as more of a reallocation of resources to support other, higher-growth ...
Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to ...
Along with its financial results for the second quarter of 2025, Merck revealed a restructuring plan to save $3 billion by ...
Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said ...
Merck & Co said on Tuesday it was extending its hold on Gardasil shipments to China until at least the end of 2025 due to ...
For $10 billion, Merck is acquiring a promising healthcare company which is in the early stages of its growth. Key to its potential is Ohtuvayre, a blockbuster drug that regulators approved last year ...
Merck said it is embarking on a multi-year cost-savings plan, which includes cuts to its workforce and real-estate footprint, ...
Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback